Neurobehavioral endpoint planning
Frame the package around the first decision your team needs from the data.
Preclinical proof for neuropeptide research compound
Build Semax evidence before managing a lab.
VivoProof acts as a preclinical proof layer for drug builders. Start with a Semax research question, then turn it into a scoped evidence plan for systems, samples, endpoints, data closeout, and feasibility review.
Semax inquiries usually need careful planning because neurobehavioral endpoints can become expensive and model-specific fast.
Decision first
Start with the decision the data must support.
A useful request is not just a compound name. It names the decision, the system, the readouts, the reporting standard, and the constraints that could change feasibility.
Tolerability and observation screen
Map the system, comparator, sample schedule, and endpoint burden before review.
Biomarker or tissue add-ons if feasible
Decide whether the first pass needs exposure, tolerability, biomarkers, or tissue work.
Structured observation and raw data package
Specify the closeout standard so the raw tables and summary are useful after the run.
Evidence systems
Choose the smallest credible system for the question.
Many teams start by asking for animal testing. The right first package can also be a cell screen, dish assay, bioanalysis run, or tissue package when that is the smaller credible step.
Organism-level signal
Use when route, tolerability, exposure, metabolic, behavioral, or tissue-level questions cannot be answered in a dish.
Early signal before animals
Use when viability, pathway, direct-cell, or assay feasibility can reduce risk before an in vivo package.
Exposure and sample data
Use for LC-MS/MS, plasma exposure, sample handling, biomarker panels, or material-dependent readouts when available.
Local endpoint package
Use when tissue collection, necropsy, histology, imaging, or local-reaction review is part of the decision.
Inputs before scope
What a real Semax request needs.
The Proof Planner can draft a useful starting point, but the formal review depends on material documents, assay availability, sample burden, and the closeout package your team needs.
Material and study inputs
- Compound identity, storage, and available material
- Behavioral domain, model preference, and comparator idea
- Data format, video or image needs, and reporting level
Endpoint options
- Clinical observations and body weight
- Behavioral or neuro-oriented readouts where model fit is confirmed
- Optional tissue or biomarker collection when feasible
What can change feasibility
Behavioral endpoint choice, model availability, blinding/randomization expectations, and video feasibility must be confirmed before planning lock.
Output package
What your team gets back.
VivoProof coordinates the proof package and closeout so the output is useful for internal review, sponsor diligence, or the next experimental decision.
- Neuro-endpoint feasibility memo
- Observation tables and raw exports
- Summary report with model-fit caveats
- Start with the Semax question and available material context.
- Select the system, confidence level, sample map, and closeout format in Proof Planner.
- Complete contact and payment-method verification before exact estimate release.
- Feasibility, review path, and next action are confirmed online — no call required.
Public pages avoid protocols, dosing directions, treatment claims, and human-use instructions. Detailed plans are finalized only after research-use review, compound-document review, and facility review.
Next step
Design the Semax evidence plan online.
Build a first-pass proof package for the research question, system, samples, closeout, and planning range. The formal scope is locked only after qualified review.